3 FTSE Shares Hitting New Highs: Aviva plc, DS Smith plc and London Stock Exchange Group Plc

Aviva plc (LON: AV), DS Smith plc (LON: SMDS) and London Stock Exchange Group Plc (LON: LSE) end the year on a high.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The FTSE 100 (FTSEINDICES: ^FTSE) looks set to end the year around its current level of 6,750, which is only 126 points short of the 13-year record of 6,876 points set in May. Over the week so far the index is still flat, so we’ll have to wait to see if we’re to get three weeks of rises in a row.

But we do have a bullish mood boosting several sectors at the moment. Here are three shares setting new records:

Aviva

The insurance sector is having a great time right now, as a number of constituents reach new highs. Aviva (LSE: AV) (NYSE: AV.US) is one of them, with its shares hitting 452p today to take them back within a penny of their 52-week high set in November.

Aviva shares are up around 20% over the whole of the year, ahead of the FTSE’s 14%, but that has come mostly during the second half — from a low of 292p in April, the price is now up 55%.

And looking forward, the consensus valuation is not onerous — current forecasts for 2014 suggest a P/E of just 9.5, with a 3.6% dividend yield coming in ahead of the FTSE average.

DS Smith

DS Smith (LSE: SMDS) has had an even better year, with its shares soaring to a new record of 333p today — that’s a gain of more than 60% over 12 months.

The supplier of recycled packaging recorded a 36% rise in earnings per share (EPS) to April 2013, and there’s a further 20% growth forecast for the current year. Half-year results released on 5 December revealed a 30% EPS rise for the period, and the firm lifted its interim dividend by 28%.

There’s currently a 20% earnings rise penciled in for 2015 too, so a rise that’s taken the share price up nearly tenfold since a 2009 low of 33.5p could well have further to go.

London Stock Exchange

All this renewed stock market activity and fresh bullishness has given London Stock Exchange Group (LSE: LSE) itself a nice boost, taking its price to a new high of 1,736p today for an annual gain of close to 60%.

The first six months of the current year saw revenue rise by 44% to £504m, with adjusted operating profit up 6% to £230m. Adjusted EPS for the period actually dropped a little, down 7% to 48.2p, but the interim dividend was raised by 4% to 10.1p per share.

Full-year forecasts to March 2014 suggest a 5% drop in EPS, putting the shares on a P/E of 17 with a dividend yielding less than 2%. There’s 10% earnings growth predicted for 2015, but LSE shares are looking high enough to me just now.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> Alan does not own any shares mentioned in this article.

More on Investing Articles

Dividend Shares

A 12.65% yield? Here’s the dividend forecast for this FTSE income share

Jon Smith talks through the2026/27 dividend forecast for an income stock that already has a double-digit yield but could go…

Read more »

Young Asian woman holding a cup of takeaway coffee and folders containing paperwork, on her way into the office
Investing Articles

Down 23% last year, here’s a FTSE 100 share that could rebound (and then some) in 2025!

Royston Wild thinks this dirt cheap FTSE 100 share has the ingredients to bounce back after a tough few years.…

Read more »

Investing Articles

2 beaten-down shares to consider for a Stocks and Shares ISA in 2025

These high-quality businesses have suffered recent share price setbacks. This writer thinks they're now worth considering for a Stocks and…

Read more »

Fans of Warren Buffett taking his photo
Investing For Beginners

This billionaire is copying Warren Buffett. Should I do the same?

Jon Smith reviews fresh news about how an investment billionaire is imitating Warren Buffett as he goes after an interesting…

Read more »

Investing Articles

I expect these 3 FTSE 100 shares to fly when inflation really starts to fall

Harvey Jones picks out three FTSE 100 shares whose fortunes should improve once inflation is finally on the run. They're…

Read more »

Investing Articles

After a positive Q4 update, is the Vistry share price set to bounce back?

The Vistry share price has been falling sharply as a result of cost issues in its South Division. But the…

Read more »

Investing Articles

Is it game over for the Diageo share price?

The Diageo share price is showing as much spirit as an alcohol-free cocktail. Harvey Jones is wondering whether he should…

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 key reasons why AstraZeneca’s share price looks a steal to me right now

AstraZeneca’s share price has fallen a long way from its record-breaking level last year, which indicates that I may be…

Read more »